Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
AUTOR(ES)
Zimmer, Andreas
FONTE
The National Academy of Sciences
RESUMO
Δ9-Tetrahydrocannabinol (Δ9-THC), the major psychoactive ingredient in preparations of Cannabis sativa (marijuana, hashish), elicits central nervous system (CNS) responses, including cognitive alterations and euphoria. These responses account for the abuse potential of cannabis, while other effects such as analgesia suggest potential medicinal applications. To study the role of the major known target of cannabinoids in the CNS, the CB1 cannabinoid receptor, we have produced a mouse strain with a disrupted CB1 gene. CB1 knockout mice appeared healthy and fertile, but they had a significantly increased mortality rate. They also displayed reduced locomotor activity, increased ring catalepsy, and hypoalgesia in hotplate and formalin tests. Δ9-THC-induced ring-catalepsy, hypomobility, and hypothermia were completely absent in CB1 mutant mice. In contrast, we still found Δ9-THC-induced analgesia in the tail-flick test and other behavioral (licking of the abdomen) and physiological (diarrhea) responses after Δ9-THC administration. Thus, most, but not all, CNS effects of Δ9-THC are mediated by the CB1 receptor.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=21937Documentos Relacionados
- Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice
- Cannabinoid CB1 Receptor-Dependent Long-Term Depression in Autaptic Excitatory Neurons
- Efeitos da eletroacupuntura sobre a expressão de receptores canabinóides CB1 em camundongos abstinentes ao etanol
- 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor
- CB1 Cannabinoid Receptors Modulate Kinase and Phosphatase Activity During Extinction of Conditioned Fear in Mice